Singapore markets close in 27 minutes

Straits Times Index
3,299.57
+2.68(+0.08%)
Nikkei
38,236.07
-37.98(-0.10%)
Hang Seng
18,475.92
+268.79(+1.48%)
FTSE 100
8,202.29
+30.14(+0.37%)
Bitcoin USD
59,294.02
+1,419.64(+2.45%)
CMC Crypto 200
1,291.43
+14.45(+1.13%)

Summit Hotel Properties, Inc. (INN)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

6.18

+0.11

(+1.81%)

At close: 04:00PM EDT

6.11

-0.07

(-1.13%)

After hours:

05:05PM EDT

Loading interactive chart…

GuruFocus.com
Summit Hotel Properties Inc (INN) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Discover how Summit Hotel Properties Inc achieved significant financial improvements and strategic milestones in the first quarter of 2024.
PR Newswire
SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2024 RESULTS
Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), today announced results for the three months ended March 31, 2024.
CNW Group
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce that is has reached a key milestone: the Company submitted its letter of application for a Pre-IND meeting, the first phase in the FDA approval process in the United States for Innocan's Liposome-Cannabidiol (LPT-CBD) injectable treatment of chronic pain.